These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families. Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB BMC Med Genet; 2010 Mar; 11():48. PubMed ID: 20350294 [TBL] [Abstract][Full Text] [Related]
4. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients. Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639 [TBL] [Abstract][Full Text] [Related]
5. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Lawson VH; Graham BV; Flanigan KM Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786 [TBL] [Abstract][Full Text] [Related]
6. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease]. Sołtysińska E; Kabzińska D; Kochański A Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344 [TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal Charcot-Marie-Tooth disease. Bergamin G; Boaretto F; Briani C; Pegoraro E; Cacciavillani M; Martinuzzi A; Muglia M; Vettori A; Vazza G; Mostacciuolo ML Neuromolecular Med; 2014 Sep; 16(3):540-50. PubMed ID: 24819634 [TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study. Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot-Marie-Tooth neuropathy type 2. Cho HJ; Sung DH; Kim BJ; Ki CS Clin Genet; 2007 Mar; 71(3):267-72. PubMed ID: 17309650 [TBL] [Abstract][Full Text] [Related]
11. Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations. Polke JM; Laurá M; Pareyson D; Taroni F; Milani M; Bergamin G; Gibbons VS; Houlden H; Chamley SC; Blake J; Devile C; Sandford R; Sweeney MG; Davis MB; Reilly MM Neurology; 2011 Jul; 77(2):168-73. PubMed ID: 21715711 [TBL] [Abstract][Full Text] [Related]
12. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246 [TBL] [Abstract][Full Text] [Related]
13. Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation. Di Meglio C; Bonello-Palot N; Boulay C; Milh M; Ovaert C; Levy N; Chabrol B Brain Dev; 2016 May; 38(5):498-506. PubMed ID: 26686600 [TBL] [Abstract][Full Text] [Related]
14. A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype. Iapadre G; Morana G; Vari MS; Pinto F; Lanteri P; Tessa A; Santorelli FM; Striano P; Verrotti A Eur J Paediatr Neurol; 2018 May; 22(3):563-567. PubMed ID: 29361379 [TBL] [Abstract][Full Text] [Related]
16. MFN2-related genetic and clinical features in a cohort of Chinese CMT2 patients. Xie Y; Li X; Liu L; Hu Z; Huang S; Zhan Y; Zi X; Xia K; Tang B; Zhang R J Peripher Nerv Syst; 2016 Mar; 21(1):38-44. PubMed ID: 26801520 [TBL] [Abstract][Full Text] [Related]
17. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Del Bo R; Moggio M; Rango M; Bonato S; D'Angelo MG; Ghezzi S; Airoldi G; Bassi MT; Guglieri M; Napoli L; Lamperti C; Corti S; Federico A; Bresolin N; Comi GP Neurology; 2008 Dec; 71(24):1959-66. PubMed ID: 18946002 [TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations. Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656 [TBL] [Abstract][Full Text] [Related]
19. MFN2 mutations cause severe phenotypes in most patients with CMT2A. Feely SM; Laura M; Siskind CE; Sottile S; Davis M; Gibbons VS; Reilly MM; Shy ME Neurology; 2011 May; 76(20):1690-6. PubMed ID: 21508331 [TBL] [Abstract][Full Text] [Related]
20. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A. Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]